Kensuke Kaneko

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Fluorescence Imaging

Photodynamic Therapy

Heat Shock Protein

Top Venues

Molecular cancer therapeutics

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Takuya Osada, Erika J Crosby, Kensuke Kaneko, Joshua C Snyder, Joshua D Ginzel, Chaitanya R Acharya, Xiao-Yi Yang, Thomas J Polascik, Ivan Spasojevic, Rendon C Nelson, Amy Hobeika, Zachary Conrad Hartman, Leonard M Neckers, André Rogatko, Philip F Hughes, Jiaoti Huang, Michael A Morse, Timothy Haystead, Herbert Kim Lyerly
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study. Molecular cancer therapeutics (2021)
Kensuke Kaneko, Takuya Osada, Michael A Morse, William R Gwin, Joshua D Ginzel, Joshua C Snyder, Xiao-Yi Yang, Cong-Xiao Liu, Marcio Augusto Diniz, Khaldon Bodoor, Philip F Hughes, Timothy Aj Haystead, Herbert Kim Lyerly
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Communications biology 3 (1) (2020)